BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1342221)

  • 1. Effect of cutaneous cell-mediated immune response to rIFN gamma on Mycobacterium leprae viability in the lesions of lepromatous leprosy.
    Damasco MH; Sarno EN; Lobão AS; Alvarenga FB; Porto JA; Rosankaimer F; Kaplan G
    Braz J Med Biol Res; 1992; 25(5):457-65. PubMed ID: 1342221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients.
    Kaplan G; Nusrat A; Sarno EN; Job CK; McElrath J; Porto JA; Nathan CF; Cohn ZA
    Am J Pathol; 1987 Aug; 128(2):345-53. PubMed ID: 3113256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
    Katoch K; Katoch VM; Natrajan M; Bhatia AS; Sreevatsa ; Gupta UD; Sharma VD; Shivannavar CT; Patil MA; Bharadwaj VP
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
    Kaplan G; Kiessling R; Teklemariam S; Hancock G; Sheftel G; Job CK; Converse P; Ottenhoff TH; Becx-Bleumink M; Dietz M
    J Exp Med; 1989 Mar; 169(3):893-907. PubMed ID: 2494293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
    Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
    Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.
    Nathan CF; Kaplan G; Levis WR; Nusrat A; Witmer MD; Sherwin SA; Job CK; Horowitz CR; Steinman RM; Cohn ZA
    N Engl J Med; 1986 Jul; 315(1):6-15. PubMed ID: 3086725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leprosy pseudoimbricata: an unusual presentation of steroid-modified borderline lepromatous leprosy.
    Kumar S; Mehta H; Aggarwal D; Chatterjee D; Narang T; Dogra S
    Int J Dermatol; 2020 Apr; 59(4):e124-e125. PubMed ID: 31957882
    [No Abstract]   [Full Text] [Related]  

  • 10. Lepromatous leprosy treated with recombinant interferon gamma: cutaneous histologic changes.
    Bottasso O; Besuschio S; Merlin V; Morini JC; Bernabo J; Falcoff R; Falcoff E
    Int J Dermatol; 1992 Nov; 31(11):813-7. PubMed ID: 1428437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of multiple interferon gamma injections on the disposal of Mycobacterium leprae.
    Kaplan G; Mathur NK; Job CK; Nath I; Cohn ZA
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8073-7. PubMed ID: 2510159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.
    Kaplan G; Sampaio EP; Walsh GP; Burkhardt RA; Fajardo TT; Guido LS; de Miranda Machado A; Cellona RV; Abalos RM; Sarno EN
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6269-73. PubMed ID: 2668961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant interferon gamma administration on lesional monocytes/macrophages in lepromatous leprosy patients.
    SivaSai KS; Prasad HK; Misra RS; Ramesh V; Wilfred D; Nath I
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):259-69. PubMed ID: 8396615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa ; Sharma VD; Shivannavar CT; Katoch VM
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):451-7. PubMed ID: 2664042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.
    Kaplan G; Britton WJ; Hancock GE; Theuvenet WJ; Smith KA; Job CK; Roche PW; Molloy A; Burkhardt R; Barker J
    J Exp Med; 1991 Apr; 173(4):993-1006. PubMed ID: 2007862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
    Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
    Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.
    Sampaio EP; Moreira AL; Sarno EN; Malta AM; Kaplan G
    J Exp Med; 1992 Jun; 175(6):1729-37. PubMed ID: 1588290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.